Mckesson Corp(MCK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:09 PM ET (Korea 10/27 05:09)
Full metrics table
| Index | S&P 500 | P/E | 26.57 | EPS (ttm) | 37.37 | Insider Own | 0.06% | Shs Outstand | 116.6M | Perf Week | -1.74% |
| Market Cap | 115.76B | Forward P/E | 19.61 | EPS next Y | 13.39% | Insider Trans | -31.23% | Shs Float | 116.5M | Perf Month | 14.57% |
| Enterprise Value | 125.14B | PEG | 1.4 | EPS next Q | 10.72 | Inst Own | 94.33% | Short Float | 1.96% | Perf Quarter | 11.62% |
| Income | 4.59B | P/S | 0.28 | EPS this Y | 14.14% | Inst Trans | -2.68% | Short Ratio | 2.56 | Perf Half Y | 19.87% |
| Sales | 410.98B | P/B | - | EPS next 5Y | 13.99% | ROA | 5.41% | Short Interest | 2.29M | Perf YTD | 21.04% |
| Book/sh | -36.55 | P/C | 22.02 | EPS past 3/5Y | 15.3% - | ROE | - | 52W High | -3.63% ($1030.27) | Perf Year | 23.85% |
| Cash/sh | 45.08 | P/FCF | 18.04 | Sales past 3/5Y | 13.39% 11.11% | ROIC | 78.2% | 52W Low | 37.2% ($723.68) | Perf 3Y | 119.84% |
| Dividend Est. | $3.19 (0.32%) | EV/EBITDA | 16.73 | EPS Y/Y TTM | 48.98% | Gross Margin | 3.43% | Volatility(W/M) | 2.22% 2.24% | Perf 5Y | 377.41% |
| Dividend TTM | 3.4 | EV/Sales | 0.3 | Sales Y/Y TTM | 8.84% | Oper. Margin | 1.63% | ATR (14) | 22.25 | Perf 10Y | 526.14% |
| Dividend Ex-Date | 2026/12/1 | Quick Ratio | 0.52 | EPS Q/Q | -17.54% | Profit Margin | 1.12% | RSI (14) | 63.22 | Recom | 1.65 |
| Dividend Gr. 3/5Y | 14.9% 13.68% | Current Ratio | 0.89 | Sales Q/Q | 7.72% | SMA20 | 3.99% ($954.77) | Beta | 0.28 | Target Price | $1021.64 |
| Payout | 8.26% | Debt/Eq | - | Earnings | 2026/11/4 | SMA50 | 8.8% ($912.56) | Rel Volume | 0.57 | Prev Close | $1000.77 |
| Employees | 43000 | LT Debt/Eq | - | EPS/Sales Surpr. | 3.86% 1.45% | SMA200 | 15.5% ($859.63) | Avg Volume(3M) | 0.89M | Price | $992.87 |
| IPO | 1994/11/10 | Option/Short | Yes/Yes | Trades | 17997 | Volume | 508,147 | Change | -0.79% |
💊 This is one of the "Big Three" U.S. pharmaceutical distributors and a comprehensive healthcare company that provides global pharmaceutical distribution and medical solutions. Founded in 1833 and headquartered in the U.S., it has established itself as a core player in the U.S. prescription drug distribution market.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded less than usual. That is 57% of its average volume.
Next earnings report: November 4
9 days to go.
MCK has weak earnings and a weak balance sheet
Of every $100 in sales, $1.63 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.1% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,673. Peers typically go for $1,528. It is about in line with its own 5-year average.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +377.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.32% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 94.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It is the largest in the industry
Based on market cap of $116B.
MCK#1 Mckesson Corp $116B PER 26.6 
COR#2 Cencora Inc $63B PER 24.5 
CAH#3 Cardinal Health Inc $58B PER 34.8 
HSIC#4 Henry Schein Inc $9B PER 24.6 
AHG#5 Akso Health Group ADR $1B PER - 
FAQ
What kind of company is MCK?
MCK belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of MCK?
The market cap of MCK is approximately $115.8B, ranking 141 within its sector.
Does MCK pay dividends?
MCK has a dividend yield of approximately 0.32%, with an annual dividend of $3.19.
What is the P/E ratio of MCK?
MCK has a P/E ratio of approximately 26.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MCK?
MCK has recorded a 52-week high of $1030.27 and a low of $723.68.
